Company Filing History:
Years Active: 2020-2024
Title: Yong Bhum Song: Innovator in GPCR Heteromer Inhibitors
Introduction
Yong Bhum Song is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer research through his innovative work on G protein-coupled receptor (GPCR) heteromer inhibitors. With a total of 2 patents, his inventions are paving the way for new therapeutic approaches in oncology.
Latest Patents
One of Yong Bhum Song's latest patents focuses on GPCR heteromer inhibitors and their uses. This invention pertains to inhibitors of CXC receptor 4 (CXCR4)-G protein-coupled receptor (GPCR) heteromers associated with cancers. Specifically, it addresses how CXCR4 forms a functional heteromer with other GPCRs, known as GPCRx. The invention highlights that co-stimulation with CXCR4 agonists and GPCRx agonists enhances signaling downstream of CXCR4. Furthermore, it provides methods for using inhibitors of the interacting GPCR partner of the CXCR4-GPCRx heteromer, including specific inhibitors and antibodies for the diagnosis and therapy of cancer.
Career Highlights
Yong Bhum Song is currently associated with GPCR Therapeutics, Inc., where he continues to advance his research in GPCR heteromers. His work is crucial in understanding the complex interactions of GPCRs and their implications in cancer treatment.
Collaborations
He collaborates with esteemed colleagues such as DongSeung Seen and Eunhee Kim, contributing to a dynamic research environment focused on innovative cancer therapies.
Conclusion
Yong Bhum Song's contributions to the field of GPCR heteromer inhibitors represent a significant advancement in cancer research. His innovative patents and collaborative efforts are essential in the ongoing fight against cancer.